Primer: TenNor Therapeutics (Suzhou) Limited (TEN123 HK) - Aug 2026
TenNor Therapeutics is a clinical-stage biotechnology company nearing commercialization, with a strategic focus on developing novel therapeutics...
98 Views
TenNor Therapeutics (丹诺医药) IPO Trading
TenNor Therapeutics raised USD 76.9m to list on HKEX on Friday, May 22. Retail demand is strong, but institutional subscription was modest. We also...
133 Views
TenNor Therapeutics (丹诺医药) IPO: Rich Valuation for an Antibacterial Deal
We analyze TenNor IPO, which targets USD 80m HK listing. We would avoid it given its rich valuation anchoring on H.Pylori indication and market...
163 Views
TenNor Therapeutics (丹诺医药) Pre-IPO: AP Updates and Further Research
TenNor Therapeutics aims to raise $100m through Hong Kong listing with CITIC and ABCI as joint sponsors. The company refiled application proof. We...
282 Views
HSCI Index Rebalance Preview and Stock Connect (Sep 2026): Adds Outnumber Deletes as IPOs Dominate
There could be 80 changes for the HSCI in March. That could result in 70 changes to the Southbound Stock Connect list and also have implications...
237 Views